Capstone C800S Microturbine to Power Large Pharmaceutical Company in California

CHATSWORTH, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) — Capstone Turbine Corporation (www.capstoneturbine.com) (Nasdaq:CPST), the world’s leading clean technology manufacturer of microturbine energy systems, announced today…

capstone-auth-distr

CHATSWORTH, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) — Capstone Turbine Corporation (www.capstoneturbine.com) (Nasdaq:CPST), the world’s leading clean technology manufacturer of microturbine energy systems, announced today that its California distributor received an order for a C800 Signature Series microturbine to upgrade a large pharmaceutical company in Northern California.

Regatta Solutions, Capstone’s distributor in California, secured the order, which is expected to be commissioned in December 2016. The customer selected Capstone microturbines over reciprocating engines due to their ability to provide 24/7 secure power while also meeting strict Bay Area Air Quality Management District (BAAQMD) Best Available Control Technology (BACT) emissions levels, which allow the system to operate continuously and not just as a backup power source.
The natural gas-fueled C800S microturbine will be installed in dual mode to provide both prime and secure back up power for the facility. The electricity-only configuration will also mitigate first and second order power security threats, whether it be a utility grid failure or cut in fuel supply. Once installed, the microturbine energy system is expected to significantly reduce operating costs while also protecting highly sensitive manufacturing process loads. Additionally, the customer intends to expand their utilization of the microturbine by adding heat recovery equipment in 2017.
“We are seeing a growing number of companies that have created a multi-dimensional strategy to reduce greenhouse gas emissions while delivering smarter, more resilient electric power to their enterprises,” said Steven Acevedo, President and CEO of Regatta Solutions. “Large, highly technical manufacturing processes will continue to look for operational cost savings while complying with environmental regulation and maintaining secure power to their facilities. Capstone’s technology has the ability to do all three of these things,” added Mr. Acevedo.
“Pharmaceutical companies require a steady and reliable source of energy to develop their products as efficiently as possible and Capstone is dedicated to helping these businesses achieve high energy availability and operational efficiency while working toward their goals for long-term sustainability,” said Jim Crouse, Capstone’s Executive Vice President of Sales and Marketing.
About Capstone Turbine Corporation
Capstone Turbine Corporation (www.capstoneturbine.com) (Nasdaq:CPST) is the world’s leading producer of low-emission microturbine systems and was the first to market commercially viable microturbine energy products. Capstone has shipped approximately 8,800 Capstone Microturbine systems to customers worldwide. These award-winning systems have logged millions of documented runtime operating hours. Capstone is a member of the U.S. Environmental Protection Agency’s Combined Heat and Power Partnership, which is committed to improving the efficiency of the nation’s energy infrastructure and reducing emissions of pollutants and greenhouse gases. A UL-Certified ISO 9001:2015 and ISO 14001:2015 certified company, Capstone is headquartered in the Los Angeles area with sales and/or service centers in the United States, Latin America, Europe, Middle East, China and Singapore.
This press release contains “forward-looking statements,” as that term is used in the federal securities laws, about further expansion into CHP applications, the advantages of our CHP applications, and their ability to provide secure power, reduce operating costs, protect sensitive manufacturing process loads, and meet emission levels. Forward-looking statements may be identified by words such as “expects,” “objective,” “intend,” “targeted,” “plan” and similar phrases. These forward-looking statements are subject to numerous assumptions, risks and uncertainties described in Capstone’s filings with the Securities and Exchange Commission that may cause Capstone’s actual results to be materially different from any future results expressed or implied in such statements. Capstone cautions readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Capstone undertakes no obligation, and specifically disclaims any obligation, to release any revisions to any forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.
“Capstone” and “Capstone Microturbine” are registered trademarks of Capstone Turbine Corporation. All other trademarks mentioned are the property of their respective owners.
View Full Article Here: Capstone-C800S-Microturbine-to-Power-Large-Pharmaceutical-Company-in-California